ArticleFrontiers in genetics2021

MeImmS: Predict Clinical Benefit of Anti-PD-1/PD-L1 Treatments Based on DNA Methylation in Non-small Cell Lung Cancer.

Shipeng Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.